BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haghshenas MR, Arabi M, Mousavi T. Hepatitis B genotypes in iran. Mater Sociomed 2014;26:129-33. [PMID: 24944540 DOI: 10.5455/msm.2014.26.129-133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mousavi T, Haghshenas MR, Rafiei A, Navaei RA, Khah ZH. Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014. Med Arch 2014;68:376-80. [PMID: 25648402 DOI: 10.5455/medarh.2014.68.376-380] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Behzadi MA, Leyva-Grado VH, Namayandeh M, Ziyaeyan A, Feyznezhad R, Dorzaban H, Jamalidoust M, Ziyaeyan M. Seroprevalence of viral hepatitis A, B, C, D and E viruses in the Hormozgan province southern Iran. BMC Infect Dis 2019;19:1027. [PMID: 31795979 DOI: 10.1186/s12879-019-4661-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
3 Keshvari M, Alavian SM, Sharafi H. Comparison of Serum Hepatitis B Virus DNA and HBsAg Levels Between HBeAg-Negative and HBeAg-Positive Chronic Hepatitis B Patients. Jundishapur J Microbiol 2015;8:e21444. [PMID: 25973160 DOI: 10.5812/jjm.21444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Nodeh MM, Mosavat A, Valizadeh N, Zadeh AM, Boskabadi A, Mashkani B, Sima H, Rafatpanah H. Genotype characteristic and phylogenetic analysis of hepatitis B virus in northeast-Iran. Infect Genet Evol 2018;59:148-54. [PMID: 29425854 DOI: 10.1016/j.meegid.2018.02.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Liu T, Tian L, Fu X, Wei L, Li J, Wang T. Saffron inhibits the proliferation of hepatocellular carcinoma via inducing cell apoptosis. Panminerva Med 2020;62:7-12. [PMID: 30657284 DOI: 10.23736/S0031-0808.18.03561-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Ansari MHK, Rasmi Y, Abbasi L. Hepatitis B virus Genotypes in West Azarbayjan Province, Northwest Iran. Open Access Maced J Med Sci 2017;5:875-9. [PMID: 29362612 DOI: 10.3889/oamjms.2017.206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Ziaee M, Javanmard D, Sharifzadeh G, Hasan Namaei M, Azarkar G. Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran. Hepat Mon 2016;16:e37806. [PMID: 27882062 DOI: 10.5812/hepatmon.37806] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Javanmard D, Namaei MH, Farahmand M, Ziaee A, Amini E, Ziaee M. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. J Med Virol 2019;91:1519-27. [PMID: 30908666 DOI: 10.1002/jmv.25470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
9 Athamneh RY, Arıkan A, Sayan M, Mahafzah A, Sallam M. Variable Proportions of Phylogenetic Clustering and Low Levels of Antiviral Drug Resistance among the Major HBV Sub-Genotypes in the Middle East and North Africa. Pathogens 2021;10:1333. [PMID: 34684283 DOI: 10.3390/pathogens10101333] [Reference Citation Analysis]
10 Bagheri-Jamebozorgi M, Keshavarz J, Nemati M, Mohammadi-Hossainabad S, Rezayati MT, Nejad-Ghaderi M, Jamalizadeh A, Shokri F, Jafarzadeh A. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy. Hum Vaccin Immunother 2014;10:3731-6. [PMID: 25483689 DOI: 10.4161/hv.34393] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
11 Keshavarz K, Kebriaeezadeh A, Alavian SM, Akbari Sari A, Rezaei Hemami M, Lotfi F, Hashemi Meshkini A, Javanbakht M, Keshvari M, Nikfar S. A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model. Hepat Mon 2016;16:e37435. [PMID: 27822262 DOI: 10.5812/hepatmon.37435] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
12 Khairkhah T, Shamsa A, Roohi A, Khoshnoodi J, Rajabpour VF, Tabrizi M, Zarei S, Golsaz-Shirazi F, Shokri F. Analysis of Knowledge, Attitudes, and Prevalence of Hepatitis B and C Seromarkers Among Barbers in Tehran. Hepat Mon 2016;16:e39416. [PMID: 27822265 DOI: 10.5812/hepatmon.39416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Husseini AA, Islam Saeed KM, Yurdcu E, Bozdayı AM. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turk J Gastroenterol 2020;31:658-66. [PMID: 33090103 DOI: 10.5152/tjg.2020.19169] [Reference Citation Analysis]